Approvals/TGA/TAKHZYRO lanadelumab 150 mg/1 mL solution for injection pre-filled syringe

Approved

STANDARD

TAKHZYRO lanadelumab 150 mg/1 mL solution for injection pre-filled syringe

Takeda Pharmaceuticals Australia Pty Ltd🇦🇺 Therapeutic Goods Administration

Approval Id: 9d6c66be76fe9b83
Product Name: TAKHZYRO lanadelumab 150 mg/1 mL solution for injection pre-filled syringe
Artg Id: 409942
Artg Name: TAKHZYRO lanadelumab 150 mg/1 mL solution for injection pre-filled syringe
Sponsor: Takeda Pharmaceuticals Australia Pty Ltd
Company Detail Path: /organization/takeda-pharmaceuticals-australia-pty-ltd
Artg Date: 2024-07-25
Registration Type: Medicine
Therapeutic Good Type: Medicine
Licence Status: A
Licence Category: RE
Consumer Medicine Info: https://medical-cdn.nocode.com/drug_tga/db8e8364a80e362f48d10d9d3641b77a.pdf
Product Information: https://medical-cdn.nocode.com/drug_tga/72a8cf9e013795cffc120225559e99b0.pdf

Approved

Agency

TGA

Country

🇦🇺

Approval Date

May 30, 2025

Approval ID

9d6c66be76fe9b83

Type

Standard